INGN Earnings Date: Nov 5, 2026 (Estimated) — Inogen, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is INGN's next earnings date?
Inogen, Inc. (INGN) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.11 on revenue of $92.2M.
How did INGN do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Inogen, Inc. posted EPS of $0.00 versus the -$0.15 estimate, a beat of 100.0%. Revenue was $95.1M against a $95.2M estimate. The stock's 1-day post-earnings move was -6.8%.
How much does INGN stock move after earnings?
INGN beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.3% (up or down) in the day after earnings.
About Inogen, Inc.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.15 | 0.00 | +100.00% | $95.1M | ✅ Beat | -6.78% | -10.48% | -16.49% |
| 2026-05-07 | Q1 2026 | -0.22 | -0.14 | +36.36% | $85.1M | ✅ Beat | -2.36% | -5.42% | -15.72% |
| 2026-02-24 | Q4 2025 | -0.25 | -0.15 | +40.00% | $81.7M | ✅ Beat | +2.91% | +6.34% | +9.93% |
| 2025-11-05 | Q3 2025 | -0.14 | -0.02 | +85.71% | $92.4M | ✅ Beat | -8.31% | -13.28% | -13.28% |
| 2025-08-07 | Q2 2025 | -0.14 | -0.02 | +85.71% | $92.3M | ✅ Beat | +10.39% | +30.66% | +43.95% |
| 2025-02-25 | Q4 2024 | -0.49 | -0.24 | +51.02% | $80.1M | ✅ Beat | -14.81% | -15.65% | -24.68% |
| 2024-11-07 | Q3 2024 | -0.49 | -0.11 | +77.55% | $88.8M | ✅ Beat | +17.23% | +5.18% | +0.53% |
| 2024-08-06 | Q2 2024 | -0.54 | -0.07 | +87.04% | $88.8M | ✅ Beat | +35.95% | +53.25% | +43.56% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $95.1M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 56.6% | $53.8M | -4.5% | $110.0M | $50.3M | $56.4M | $54.0M |
| Non-US | 43.4% | $41.3M | +14.8% | $58.8M | $32.0M | $35.9M | $38.4M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.